cancer treatment

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE
TWU Biology Team Granted a Patent for Anti-Cancer Compounds That Could Save Lives
by | Oct 15, 2020
The novel invention from researchers at Texas Woman’s University in Denton could greatly contribute to cancer treatment research. The compounds can prevent the growth of breast, lung, and colon cancer cells.
MORE
Caris Life Sciences Acquires Pharmatech to Pair Patients with Clinical Trials, Faster
by | May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE